Digital health app to help manage Chronic Obstructive Pulmonary Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project explores the feasibility of a mobile application called 'Pust Deg Bedre' designed to assist patients with Chronic Obstructive Pulmonary Disease (COPD) in self-management. The app provides tailored breathing and airway clearance techniques based on individual clinical assessments. Over an 8-week intervention period, patients will engage with the app, supported by physiotherapists who will provide training and follow-up. The study will collect both quantitative and qualitative data to evaluate the app's acceptability and effectiveness in managing symptoms like dyspnea and mucus secretion.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of Chronic Obstructive Pulmonary Disease
* Mucus-related issues ≥3 times per week
* Speak and write Norwegian
* Ability to independently operate a smartphone and/or iPad

Exclusion Criteria:

* Severe mental illness
* Substance abuse that hinder participation in the study

Where it's running

• Western Norway University of Applied Sciences
  Bergen, Norway, Norway Recruiting

Study contacts

• Principal investigator: Bente Frisk, PHD — Western Norway University of Applied Sciences
• Study coordinator: Bente Frisk, PHD
• Email: bente.frisk@hvl.no
• Phone: 0047- 55587143

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

• Targeted NMES to improve breathing and leg/extra muscle strength in COPD

  This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.

  Recruiting Universitas Padjadjaran · Bandung, West Java · NCT07910006

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• PBMT with a pulmonary rehab program for COPD patients

  A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.

  Recruiting Federal University of Health Science of Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07878884

• Automated ABPI for Peripheral Artery Disease: A Pilot Look at Two Devices

  This pilot checks if two automated ankle-brachial pressure index devices can reliably detect PAD across symptom levels and after bypass surgery, using patient and clinician feedback for practicality.

  Recruiting Hull University Teaching Hospitals NHS Trust · Hull · NCT07850349

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.